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Summary 
Candidate superantigens were screened for their ability to induce lysis of human histocompati- 
bility leukocyte antigen class II-positive targets by human CD8 + influenza-specific cytotoxic T 
cell (CTL) lines. Clostridium  perfringens enterotoxin (CPET) induced major histocompatibility 
complex unrestricted killing by some but not all CTL lines. Using "anchored"  polymerase chain 
reactions, CPET was shown to selectively stimulate peripheral blood lymphocytes bearing T 
cell receptor V~ 6.9 and V~22 in five healthy donors. V324, V/~21, V318, V/~5, and VB6.1-5 
appeared to be weakly stimulated. Antigen processing was not required for CPET to induce 
proliferation. Like the staphylococcal enterotoxins, CPET is a major cause of food poisoning. 
These data suggest that superantigenic and enterotoxigenic properties may be closely linked. 
T 
he term superantigen (SA) has been applied to a group 
of bacterial and retroviral proteins that stimulate large 
numbers of T  lymphocytes in a manner distinct from that 
of dassical antigens (1). SA bind to the TCR VB chain of 
both CD4-  and CD8 + T  cells (2),  are mitogenic at nM 
concentrations, and do not require processing (3).  SA bind 
MHC class II molecules selectively  and with high aftinity 
(4,  5),  although  they  may also  bind  other  ligands  (6). 
Staphylococcal toxic shock syndrome toxin 1 (TSST) is im- 
plicated in toxic shock (7), and the staphylococcal enterotoxins 
(SE) are potent emetics, although it is not dear if their emetic 
action is a direct result of their superantigenic properties (8). 
In this report we show that the 34-kD enterotoxin pro- 
duced by Clostridium perfringens (CPET) is a superantigen with 
a novel specificity  for human TCR V~ chains. 
Materials and Methods 
Purification of  Enterotoxins. SEA and SEB were purified from cub 
ture supernatants  by dye ligand aff~ty  chromatography  as described 
(9). TSST was a gift from Rossalyn Brehm (Public Health Labora- 
tory Service, Wilts, UK). CPET was purified as described previ- 
ously (10). 
Cytotoxic T Cell Lines and Clones. Influenza A virus-specific  CTL 
lines were generated as described previously (11). Influenza A ma- 
trix peptide 57-68 was used to generate HLA A2-restricted CTL 
from donor JM (HLA A2 B15,51 Dr11) (11), and nucleoprotein  (NP) 
380-391 to generate HLA B27-restricted CTL (12) from donors 
GK (HLA A3,31 B27 DK4) and SD (HLA A2,32 B27,49 DR4 
DQ8). CTL clones were obtained by limiting dilution. TCR usage 
of JM,  GR, and SD CTL and clones (Bowness, P., and A. J. 
McMichael, manuscript in preparation) was studied using the PCR 
as described  below. CTL lysis  assays  were performed as described  pre~ 
viously (11). 
Proliferation Assays. PBMC from donor NW (HLA A3,31 B8,27 
DR3,14)  were cultured  with  APC  in  96-well plates  at  10  s 
cells/well. As APC  autologous PBL were fixed with 0.025% 
glutaraldehyde for 90 s before adding 0.2 M lysine, washing three 
times, and irradiating (5,000 rad). APC were incubated for 2 h 
with purified protein derivative 1:200 (PPD 100,000 U/ml; Evans 
Medical, Langhurst, UK), CPET, SEE or PHA at 5/~g/ml before 
washing twice. After 5 d 1 #Ci [3H]thymidine was added, cells 
were harvested after 6 h and counted by standard scintillation tech- 
niques. 
Selection of Activated Lymphocytes. PBL, cultured for 72 h with 
CPET, TSST, or SEB at 100 ng/ml or PHA at 5/~g/ml, were washed 
with PBS and incubated on ice with the mAb 23A9.3 (a gift of 
C. Mawas, Institut National de la Recherche Mrdicale, Marseille, 
France), specific  for the IL-2  receptor (ID2R). Lymphocytes  bearing 
the IL-2 receptor were selected with magnetic beads coated with 
goat anti-mouse Ig (Dynal, Wirral, UK). Fresh unselected  PBMC 
or Ib2R-selected PHA-stimulated PBMC were used as controls. 
PCR Analysis of TCR VB Gene Usage. Total cellular RNA was 
extracted from CTL, unstimulated PBL, or activated  lymphocytes. 
cDNA was synthesized using an oligo dT primer and anchored 
PCR (AnPCR) was performed using primers and conditions de- 
scribed previously  (13). Amplification  products were digested with 
BgllI and NotI and cloned in a modified MDmp18 vector. Clones 
were either sequenced  using T7 DNA polymerase or blotted onto 
nitrocellulose and hybridized with radiolabeled oligonucleotide 
probes for C~ (5'-CGACTTCGGGTGGGAACAC); Vfl6.9 (5'- 
TGGAGAAAGATCCCTTAG); VB22 (5'-AGTGAAATTTGAT- 
CCATCAG); and V~ 24 (5'-AAAGCAGAAAGAAGTGTT). 
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Figure  1.  (a) Lysis of autologous target cells by JM and GR CTL in 
the presence of cognate peptide or bacterial toxins. Peptides (influenza ma- 
trix 57-68 for JM, nucleoprotein 380-391 for GR) were at 1/zM. SEA, 
TSST, and CPET were at 25 nM. The E/T ratio was 2:1 for JM CTL, 
and 5:1 for GR CTL. (b) Lysis by SD CTL (HLA 2,3 B27,49 DR4 DQ8) 
of P815 cells transfected with HLA-B27  or of HLA mismatched  target 
cells in the presence of influenza nudeoprotein peptide, CPET  or SEB 
at 1/~M. The E/T ratio was 1.5:1. (c) Lysis of autologous targets by GR 
CTL in the presence of influenza nucleoprotein 380-391 or CPET in the 
concentrations  shown. The E/T ratio was 2:1. 
Results  and Discussion 
CPET Facilitates Cytolysis by Some but Not All CTL.  It 
has been  demonstrated  previously  that  CD8 +  CTL  with 
suitable TCR VB kill MHC class II-positive cells in the pres- 
1C 
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Figure  2.  Proliferation of NW PBL after 5-d culture with autologous 
irradiated APC, with or without prior glutaraldehyde fixation, incubated 
with PPD, CPET, SEB, or PHA (5/~g/ml). Mean and SD of quadrupli- 
cate [3H]thymidine uptake estimations  are shown. 
ence of superantigens at nanomolar concentrations  (2,  14, 
and P. Bowness, unpublished observations), regardless of their 
antigenic specificity. Influenza A-specific CD8 + oligoclonal 
CTL lines bearing different Vfl elements were used to screen 
potential superantigens. Such an experiment is shown in Fig 
1 a. CPET induced killing of autologous targets in the ab- 
sence of virus antigen by GR CTL (Vf124, 21, 7, 6, and 5), 
but not with JM CTL (Vf117).  This suggested that CPET 
was a superantigen with specificity for the TCR Vfl expressed 
by GR CTL, but not JM CTL. Further experiments demon- 
strated that CPET-induced CTL killing is not MHC restricted. 
SD CTL (from which clones bearing V~6,  7, and 21 were 
derived) killed only HLA B27 positive targets in the pres- 
ence of cognate peptide but killed HLA-mismatched aUogeneic 
B cell lines (but not P815 cells lacking MHC class II) in the 
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Figure  3.  TCR V~ usage of CPET-stimulated lymphocytes and PBL 
from WR. Numbers and percentages of sequenced clones of AnPCK prod- 
ucts are shown. The V~6 family is divided into VB6.1-8 and VB6.9. TCR 
VB usage of PBL from donor GR adapted from (21) with permission, 
and Rosenberg,  W. R., unpublished  data. 
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or Superantigens  from Five Unrelated Donors 
Cfl  V~6.9  V~22  vf124 
No.  No.  Percent  No.  Percent  No.  Percent 
Donor  1 
CPET  141  34N  24  20s  14  9" 
PHA  146  8  6  5  3  5 
Donor 2 
CPET  80  23 u  30  14s  18  5* 
PHA  325  26  8  18  6  5 
Donor 3 
CPET  53  5*  9  6*  11  ND 
PHA  102  2  2  1  1 
Donor 4 
CPET  201  24s  12  17s  9  ND 
PHA  137  3  2  1  1 
Donor 5 
CPET  244  17~  7  1411  6  ND 
SEB  366  3*  1  8*  2.2 
TSST  509  2"  0.4  0*  0 
PHA  435  4  1  1  0.2 
Represents TCR frequencies after culture of PBL for 72 h with CPET, 
PHA, SEB, or TSST; assigned  by oligonucleotide probing of M13-doned 
AnPCR products. The donor HLA types were: donor 1:All,33 B35,65 
DR1,4;  donor 2:A3,31 B27 DR4; donor 3:A1,3 B7,8 DR3; donor 
4:A2,29 B44 DR7;  and donor  5:A1,2 B7,8. 
"/, )  0.05 compared with PHA. 
t p <  0.05  (Pisher's exact probability). 
Sp <  0.005. 
11 p <  0.0005 (X  2 with Yates' correction). 
presence of CPET (Fig.  1 b). In contrast, two NP-specific 
HLA B27 restricted clones bearing V~7.1 (derived from GR 
and SD CTL) were CPET unresponsive (data not shown). 
CPET induced killing at nanomolar concentrations (Fig.  1 
a) that was dose dependent (Fig. 1 c), and caused modulation 
of CD3 from the CTL call surface (data  not shown). 
Ghtaraldehyde-fixed  Cells Can  Present CPET.  PBMC 
proliferated in a dose-dependent manner when incubated with 
CPET at nanomolar concentrations (data not shown). Thymi- 
dine uptake was consistently 10-fold higher than with PPD 
or tetanus toxoid, peaked 2 d earlier (data not shown), and 
was not inhibited by glutaraldehyde fixation of APCs (Fig. 
2),  indicating that antigen processing is not required. 
CPET Selectively Stimulates TCR V~6.9 and V~22.  The 
V~ distribution of CPET-stimulated lymphocytes from donor 
WR, estimated by sequencing 40 M13-doned AnPCR prod- 
ucts of lymphocyte cDNA, was markedly different from that 
of unstimulated PBL (Fig.  3).  19 of 40 sequences were of 
the V~6 family, and of these, 61% were V~6.9 (14) (com- 
pared with only 39% of PBL VB6 (W. Rosenberg, unpub- 
lished data).  Four rare VB families: VB18, 21, 22, and 24 
(15), also appeared to be sdectively stimulated by CPET. Of 
these, the most prominent was VB22 (15), which made up 
18% of sequences from CPET stimulated cells, as compared 
with < 2% of stimulated PBL. The stimulation of V~6 and 
VB21 was consistent with the cytolysis by GR and SD CTL 
(Fig.  1, a  and b). 
To confirm these findings using larger numbers, PBL from 
WR and four other unrelated donors were stimulated with 
CPET or PHA (and in one case also SEB and TSST), and 
after AnPCR recombinant M13 plaques were screened with 
oligonudeotide probes specific for the three TCR V~ that 
appeared most strongly stimulated: V~6.9, V~22, and VB24. 
The results are shown in Table 1. V~6.9 and V~22 were 
significantly stimulated by CPET in all five individuals tested 
(p <  0.05 as compared with PHA).  VB24 numbers were 
significantly increased after CPET stimulation in one of two 
donors tested. In the one individual tested, TSST stimulated 
neither V~6.9 nor VB22, but SEB was found to stimulate 
V~22 to a low but significant  extent. 
AnPCR has not previously been used to study the TCR 
repertoire of SA-stimulated PBL. Unlike the "V region family 
specific" PCR techniques used previously (16), AnPCR gives 
quantitative information about all V~ families and subfami- 
lies. Hence, CPET is the only SA for which a complete profile 
of V~ stimulation has been obtained. These findings also sup- 
port the proposition that one SA may have different affinities 
for different V~ dements (17). 
It is possible that the novel SA characterized  here is not 
CPET itself, but a contaminant of the preparations used. How- 
ever, such contamination (which is not necessarily avoided 
by using recombinant preparations) is unlikely here because 
CPET was active at nanomolar concentrations and gave only 
a single visible band after SDS gd electrophoresis under non- 
denaturing conditions (10). 
C. perfringens is the second or third most common cause 
of food poisoning in the USA (18), and the characteristic clin- 
ical features of abdominal pain and diarrhea are thought to 
be caused by CPET. CPET has also been implicated in cases 
of antibiotic-induced diarrhea, infantih diarrhea, and sudden 
infant death syndrome (reviewed in reference 19), as weU as 
in the pathogenesis of rheumatoid arthritis (20). This study 
shows that CPET is a superantigen with novel TCR VB 
specificity. It is intriguing that although it has no obvious 
structural  similarity  with  the  staphylococcal  enterotox- 
ins,  CPET shares both superantigenic and enterotoxigenic 
functions. 
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